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Abstract
Bacterial pathogens display a variety of protection mechanisms against the inhibitory and lethal
effects of host cationic antimicrobial peptides (CAMPs). To identify Yersinia pestis genes
involved in CAMP-resistance, libraries of DSY101 (KIM6 caf1 pla psa) minitransposon
Tn5AraOut mutants were selected at 37°C for resistance to the model CAMPs polymyxin B or
protamine. This approach targeted genes that needed to be repressed (null mutations) or induced
(upstream PBAD insertions) for the detection of CAMP resistance, and predictably for improved
pathogen fitness in mammalian hosts. Ten mutants demonstrated increased resistance to
polymyxin B or protamine, with the mapped mutations pointing towards genes suspected to
participate in modifying membrane components, genes encoding transport proteins or enzymes, or
the regulator of a ferrous iron uptake system (feoC). Not all the mutants were resistant to both
CAMPs used for selection. None of the polymyxin B- and only some protamine-resistant mutants,
including the feoC mutant, showed increased resistance to rat bonchoalveolar lavage fluid
(rBALF) known to contain cathelicidin and β-defensin 1. Thus, findings on bacterial resistance to
polymyxin B or protamine don’t always apply to CAMPs of the mammalian innate immune
system, such as the ones in rBALF.
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1. Introduction
Yersinia pestis is best known as the causative agent of bubonic plague, a disease transmitted
by the bite of infected fleas. However, if inhaled, this pathogen also produces a severe
© 2011 Elsevier Ltd. All rights reserved.
*Corresponding authors. Tel: +1 215 898 1685; fax: +1 215 898 7887. dmschiff@vet.upenn.edu (D.M. Schifferli). Tel: +86 10 8280
2963. Fax: +86 10 8280 5465. jitaoguo@bjmu.edu.cn (J. Guo).
‡Present address: Fundación Instituto Leloir, University of Buenos Aires and CONICET, C1405BWE-Buenos Aires, Argentina.
egalvan@leloir.org.ar
$Present address: Genomics Research Center, Harbin Medical University, 157 Baojian Road, Harbin, 150081, China.
slliu@ucalgary.ca
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Microb Pathog. Author manuscript; available in PMC 2012 September 1.
Published in final edited form as:
Microb Pathog. 2011 September ; 51(3): 121–132. doi:10.1016/j.micpath.2011.04.010.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
primary pneumonia known as pneumonic plague, which is contagious and most often lethal.
This bacterial agent uses an arsenal of virulence factors that render its entrance into the host
as surreptitious as possible. These tools are thought to be most important during the first few
hours following infection to avoid alarming the innate immune system and to avoid
phagocytosis. We and others have previously shown that in addition to being antiphagocytic,
the surface proteins F1 and Psa inhibit bacterial uptake by respiratory tract epithelial cells or
macrophages [1–3]. The antiphagocytic mechanism of Psa was suggested to be due to Psa
binding to host receptors that don’t direct internalization [4]. Y. pestis injects several
antiphagocytic proteins directly into host cells through its type III secretion system (T3SS)
[5, 6], some of which have strong anti-inflammatory properties [6–11]. In addition, Y. pestis
also makes a non-inflammatory LPS at mammalian body temperature, thereby escaping the
typical LPS-induced stimulation of TLR4 [12, 13]. Although the anti-inflammatory
activities of Y. pestis also affect DCs and their migratory properties [14, 15], Y. pestis
delivered through a fleabite still spreads to the local lymph node, causing lymphadenitis
(bubo). Further spreading steps leading to bacteremia or septicemia are not infrequent,
particularly when bubonic plague remains untreated. Plague lethality is generally assumed to
be due to sepsis. Dissemination is facilitated by core LPS, the Psa fimbriae, the outer-
membrane adhesin Ail and the plasminogen activator outer membrane protein Pla [16–20].
Pla acts as a protease that cleaves plasminogen to plasmin and mediates bacterial binding to
extracellular matrix proteins [21, 22]. It is essential for bubonic plague, (but not for
septicemic plague) after flea-mediated transmission [18, 19, 23, 24]. Pla is also essential for
the development of (but not for the dissemination from) primary pneumonic plague [25].
Y. pestis has not only evolved to survive but also to thrive in a hostile host environment that
includes the antimicrobial peptides of the innate immune system, as best exemplified by
successful bacterial replication in local lymph nodes or lungs, leading to bubonic or primary
pneumonic plague, respectively. Although the anti-inflammatory molecules of Y. pestis
might down-regulate the expression of host cationic mammalian antimicrobial peptides
(CAMPs) [26, 27], it is likely that this bacterium also expresses a battery of tools aimed at
inactivating CAMPs in vivo. Accordingly, we recently observed that Pla, through its
proteolytic activities, increased bacterial resistance to CAMPs at 37°C in vitro [48].
Curiously, this activity was counteracted in vitro by the F1 protein, an in-vivo expressed
protein, suggesting that Y. pestis might use additional mechanisms of bacterial resistance to
CAMPs. In addition to antimicrobial peptide degradation by proteases, other bacteria have
been reported to trap CAMPs extracellularly, alter their surface, particularly their surface
charge, pump CAMPs out, or modulate host cell expression or degradation of CAMPs [28,
29]. The aim of this study was to identify new Y. pestis genes involved in any of these
survival strategies. For this purpose, a minitransposon with an outward-oriented inducible
promoter was constructed and used to identify genes that either increase CAMP resistance
by being repressed (null mutants) or that demonstrate resistance by being activated
(inducible gene expression).
2. Results
2.1. Isolation of CAMP-resistant minitransposon mutants
Tn5AraOut mutants of strain DSY101 that demonstrated increased resistance to polymyxin
B or protamine were isolated as described in Materials and Methods. Briefly, Y. pestis strain
DSY101 was transformed with plasmid pTn5AraOut and bacteria were selected on
kanamycin-containing media at 37°C cont aining L-arabinose and supplemented with
polymyxin B or protamine at concentrations previously shown to inhibit strain DSY101
growth. Selection was done in the presence of arabinose to simultaneously obtain both
arabinose-dependent and -independent CAMP-resistant mutants. Consistency in the
phenotypes of clone-purified mutants was confirmed for five polymyxin-resistant and five
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protamine-resistant isolates on selective agar plates. No spontaneous resistant bacteria could
be isolated in parallel control experiments with mock(H2O)-transformed bacteria, strongly
suggesting that the isolated polymyxin- and protamine-resistant clones were due to the
minitransposon insertions. These mutants were further characterized by determining the
arabinose-dependency of their resistance and by a quantitative analysis of their CAMP
resistance levels. For this, each strain was grown in broth to log phase and further
multiplication or killing was studied in the presence or absence of CAMPs. Bacterial growth
was monitored in the presence of 0.2% arabinose, to activate the inducible promoter on the
minitransposon, or 0.2% glucose as a repressor of this promoter (negative control). All our
studies were done with bacteria grown at 37°C, since our aim was to evaluate CAMP effects
on Y. pestis at mammalian body temperature. In addition to the determination of MICs,
growth was analyzed more precisely by determining absorbance values (A600). That all the
mutants and the parental strain grew somewhat better in the presence of arabinose than in
the presence of glucose was probably related to a previously described negative effect of
glucose on Y. pestis growth [30]. However, this effect did not interfere with the
interpretation of the results concerning antimicrobial resistance, since bacterial growth of the
mutants was compared with growth of the parental strain studying both media with or
without polymyxin B. Fig. 1A shows that polymyxin B was clearly bactericidal on parental
strain DSY101 at 1.25 μg/ml or more, the lower dose of 0.625 μg/ml being still able to
inhibit bacterial growth, as compared to the bacteria in polymyxin B-free broth. In contrast,
four of the five mutants grew well at the significantly higher dose of 5 μg/ml polymyxin B,
growth of three of these resistant mutants (PB7-23, PB8-2 and PB8-4) being clearly
arabinose-dependent, since their growth was inhibited by polymyxin B only in the absence
of arabinose. Mutant PB8-8 demonstrated arabinose-independent polymyxin B-resistance,
its growth being not inhibited by polymyxin B, irrespective of the presence or absence of
arabinose (Fig. 1A). Similarly, mutant PB7-10 still grew in the presence of twice the
concentrations of polymyxin B that was killing the parental strain in the presence of
arabinose (Fig. 1A) or glucose (data not shown), indicating also arabinose-independent
polymyxin B resistance. The five mutants selected on protamine agar were able to grow
significantly in the presence of a protamine-concentration that blocked multiplication of the
parental strain DSY101 (Fig. 1B). Interestingly, protamine resistance was arabinose-
independent for all the five mutants (data not shown). Although three of the mutants grew
slower than the parental strain in the absence of protamine, mutants PM2-3 and PM3-2 grew
as well, indicating that protamine-resistance wasn’t necessarily linked to some effect on
bacterial multiplication under the used growth conditions. Taken together, the quantitative
analysis of bacterial growth in broth clearly confirmed the polymyxin B and protamine
resistance phenotypes of the mutants.
2.2. Dissociation of polymyxin B and protamine resistance
To determine whether the two CAMPs target different bacterial components or possibly
share their mode of actions, the polymyxin B resistant mutants were tested for protamine
resistance, and vice versa, using the same experimental conditions described above,
including the inducer arabinose in all the assays. Although four polymyxin B resistant
mutants were also resistant to protamine, strain PB8-8 didn’t multiply significantly with
protamine (Fig. 2A). Conversely, mutant strains PM2-3 and PM3-2 that showed resistance
to protamine were killed by polymyxin B, whereas the other three protamine resistant
mutants grew in the presence of polymyxin B (Fig. 2B). That some mutants showed a
dissociation of resistance properties between polymyxin B and protamine highlighted the
existence of different cationic peptide-specific mechanisms of CAMP resistance.
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2.3. Susceptibility of selected mutants towards rBALF antimicrobials and LL-37
Since the polymyxin B- and protamine-resistance profiles were only partially overlapping,
we wondered how the mutants would respond to constitutively expressed respiratory tract
antimicrobial peptides. Again, the assays were undertaken as described above, in the
presence of arabinose. By first testing bacterial growth in rBALF, which contains rCRAMP
[4], the rat ortholog of the human cathelicidin LL-37, it was observed that all the mutants
selected for polymyxin B resistance did not multiply (Fig. 3A). In contrast and with the
exception of strain PM2-3 and PM3-2, the three other mutants selected for protamine
resistance were able to grow in the presence of rBALF. To test these results more
specifically, we investigated growth of these mutants in the presence of the purified
mammalian CAMP, LL-37. Confirming the data obtained with rBALF, all the rBALF-
susceptible mutants were also sensitive to LL-37, as exemplified with mutant PB7-23 (Fig.
3B). The other rBALF-susceptible mutants showed comparable LL-37 concentration-
dependent killing effects, with ≥ 103 reductions of CFUs for 160 μg/ml LL-37. Conversely,
the three rBALF-resistant mutants were also resistant to LL-37 (Fig. 3B). To summarize,
only two of the polymyxin B-susceptible mutants (PM2-3 and PM3-2) were resistant to
protamine and rBALF/LL-37 and all polymyxin B-resistant mutants (most being also
protamine-resistant) were susceptible to rBALF/LL-37. These results indicated that
polymyxin B- or protamine-resistance is not necessarily representative of resistance towards
mammalian antimicrobial peptides, such as the ones of the respiratory tract.
2.4. Mapping Tn5AraOut in the CAMP-resistant mutants
The mutants were further characterized by mapping their Tn5AraOut insertion sites and
orientations as described in Materials and Methods (Table 3). Briefly, DNA including
Tn5AraOut for each of the ten resistant mutants was cloned by using different restriction
enzymes. For each mutant-restriction enzyme pair, plasmid clones of similar sizes were
obtained and DNA flanking the minitransposon inserts of these plasmids was sequenced.
Sequencing plasmids from each individual mutant always yielded the same flanking
sequences, strongly suggesting that each mutant had only one Tn5AraOut copy in its
genome. This was confirmed by Southern blot analysis using genomic DNA restricted with
either one of two different enzymes and a probe lacking the corresponding sites, each mutant
showing only one major hybridizing fragment (Supplemental Fig. 1). Moreover, since
spontaneous resistant mutants were not detected with mock transformed bacteria, the
mapped minitransposon inserts were most likely responsible for the described resistance
phenotypes. Further supportive evidence on single transposon insertions responsible for
resistance phenotypes in individual mutants were derived from detailed characterization of
mutants of interest, as described below. Three of the CAMP-resistant mutants selected with
polymyxin B had an arabinose-dependent resistance phenotype that was presumably linked
to the activation of downstream genes (Table 3 and Fig. 1A). For example, mutant PB7-23
had the arabinose-inducible promoter upstream of the pbgP operons, which includes 7
cotranscribed genes (pmrHFIJKLM or arnBCADTEF) required for the synthesis of 4-
aminoarabinose that is added to the phosphates of lipid A in Y. pestis LPS [13, 31, 32].
Arabinose-dependent induction of pmrH transcription was confirmed in this mutant by qRT-
PCR (mean ± standard error = 15.0 ± 4.5 fold increase with the inducer, n = 4, versus 1.4 ±
0.7 without inducer, n = 3, P = 0.037). The detection of such a mutant in our screen
supported our experimental method, since it had been previously shown that 4-
aminoarabinose-decorated LPS renders Y. pestis more resistant to polymyxin B. The two
other mutants with arabinose-inducible resistance to polymyxin B (PB8-4 and PB8-2) had
minitransposon insertions upstream of two single or monocistronic genes, y2568 which
encodes a hypothetical protein, and y1522 which encodes an Hcp-like protein that is not
linked to any of the five predicted type 6 secretion systems (T6SS) of Y. pestis [33]. In
contrast, two arabinose-independent polymyxin B-resistant mutants (PB7-10 and PB8-8)
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had minitransposon insertions in the promoter region of asmA and hflC orthologs of E. coli.
AsmA modulates porins, glycerophosphates and LPS levels in the outer membrane [34–36],
whereas hflC encodes a repressor of the proteolytic activity of the integral inner membrane
protein FtsH [37] which can regulate LPS concentrations through proteolysis of LpxC [38,
39]. Thus, apart from the targeted hypothetical protein, the mutants selected for increased
resistance to polymyxin B had a Tn5AraOut insertion in gene loci for bacterial envelope
components or potentially secreted molecules. Of the five additional CAMP resistant
mutants that were selected with protamine, four had mutations in orthologs of E. coli or
Salmonella transport systems, including two independent minitransposon insertions (PM2-3
and PM3-2) in the gene for the low affinity metal phosphate transporter PitA [40, 41]. The
PM2-49 mutant had its transposon insertion mapped 42 bp upstream of a predicted operator
site for the GalR repressor of the galactose import system MglBAC [42]. Polymyxin B
resistance of this mutant was arabinose-independent. This was consistent with mglB
transcription in PM2-49, which was turned on whether it was induced (mean ± standard
error = 6.9 ± 4.8 fold increased transcript levels, n= 4, as compared to the parental strain) or
not (9.2 ± 6.1 fold increased transcript levels, n = 3; induction effect P = 0.394), as detected
by qRT-PCR. Thus, the minitransposon insert of PM2-49 is suggested to have inactivated
GalR-mediated repression of the mglBAC operon [43]. The protamine-resistant mutant
PM5-6 had an insertion in y0958 that encodes a putative glycerophosphoryldiester
diesterase, designated GlpQ-like. That protamine resistance of this mutant was linked to the
inactivation of this gene and not to a potential activation of downstram dinP transcription
was confirmed by dinP qRT-PCR (comparison with the parental strain, P = 0.99). The
GlpQ-like orf predicts a significantly different primary structure than those of the E. coli (or
Y. pestis) GlpQ and UgpQ enzymes, which are involved in the intracellular uptake and
production of sn-glycerol-3-phosphate, a carbon and energy source and a precursor for novel
phospholipid synthesis and recycling of membrane phospholipids [44]. The last protamine-
resistant mutant (PM12-3) mapped in the predicted inhibitor of the ferrous iron importer
system designated Feo, as discussed later [45].
2.5. CAMP resistance and bacterial surface modifications
Most of the mutants detected in this study had Tn5AraOut insertions that were located in or
upstream of genes encoding proteins involved in membrane components or molecular
transport through membranes. LPS, a major component of the outer membrane, is known to
interact with CAMPs. Accordingly, one Tn5AraOut insertion located upstream of the pbgP
operon involved in LPS modification (Table 3, PB7-23) showed arabinose-dependent
resistance to CAMPs. Thus, we wondered whether the increased CAMP-resistance of some
of the other mutants could be related to an indirect effect on LPS. We first analyzed LPS
levels by SDS-PAGE and found no significant differences between the mutants and the
parental strain (data not shown). Subsequently, we evaluated whether the mutations affected
bacterial surface properties resulting in a reduction of CAMP binding by labeling the
bacteria grown at 37°C with dansyl-conjugated polymyxin B. Preliminary microscopic
evaluation suggested decreased binding of polymyxin B for several mutants (not shown). To
evaluate this effect in a quantitative manner, the level of binding was determined by
fluorometry. Five polymyxin B-resistant mutants (PB7-10, PB7-23, PM2-49, PM5-6 and
PM12-3) showed a significant decrease in polymyxin B binding (Fig. 4), whereas
polymyxin-B susceptible mutant PM2-3 bound polymyxin B as well as the parental strain.
These data supported the assumption that the polymyxin B-resistant mutants with the
corresponding mapped mutations (asmA, pbgP, mglB, glpQ-like and feoC) are involved in
modifying the molecules or molecular composition of the bacterial outer membrane. Other
mechanisms might explain the phenotypes of mutants PB8-4 (hypothetical gene) and PB8-2
(hcp-like gene). Arabinose-induced expression of the latter gene (y1522) in PB8-2 slightly
increased polymyxin B binding, albeit not significantly. Since Hcp proteins have been
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reported in other bacteria to be secreted in the medium, spent broth of PB8-2 was tested by
western blot analysis. Although the protein was present in the bacteria, it could not be
detected in spent broth of the minitransposon mutant (not shown). A mutant lacking the
corresponding gene and complemented with a plasmid expressing the Hcp-like protein from
an ITPG-inducible plasmid gave the same result (not shown). Increased polymyxin B
resistance was only detected in the complemented strain when production of the plasmid-
encoded protein was activated, confirming the arabinose-dependency of the minitransposon
mutant phenotype. Moreover, deletion of the neighboring y1523 gene, which could have
been affected in its promoter region (Table 3), did not increase polymyxin B resistance,
indicating that this gene was not involved in the PB8-2 phenotype. The Hcp-like protein
could not be detected in membrane fractions or on the surface of PB8-2 (not shown),
possibly because of the insufficient basal expression of a complementary type 6 export
machinery. That the observed phenotype was due to an indirect effect resulting from the
accumulation of the y1522 gene product in the cytoplasm was unlikely, since E. coli or
Salmonella enterica strains expressing the y1522 in trans were not polymyxin B resistant
(not shown).
2.6. CAMP resistance and inactivation of feoC
As expected, polymyxin B resistance of the feoC::Tn5AraOut strain and a feoC deletion
were comparably increased (Fig. 2B and Fig. 5). Since the feoC gene has been suggested to
be a repressor of the feoAB genes [45], polymyxin B resistance was thought to be associated
with feoAB derepression. Accordingly, a feoBC mutant (and a feoB mutant, not shown) was
as sensitive to polymyxin B as the parental strain DSY101 (Fig. 5). Moreover, when the
feoAB genes were expressed from an inducible vector, they overrode feoC repression in
DSY101, confirming the proposed model (Fig. 5). These results suggested that feoC
represses the feoAB genes in vitro and that the feoAB genes are involved in mediating
polymyxin B resistance. Increased FeoAB-mediated ferrous iron uptake is anticipated to
cause oxidative stress by the Fenton reaction, resulting in induction of the Fur regulon. In
addition to repressing iron uptake systems, Fur up-regulates the expression of a variety of
genes, including the ones for several surface proteins and catalase (or hydroperoxidase II)
[46]. Accordingly, the feoC::Tn5AraOut mutant was four times as much resistant to
peroxide as the parental strain (MIC of 16 mM versus 4 mM, respectively), suggesting
increased catalase expression as a response to the activation of the FeoAB-mediated ferrous
iron import. Since the feoC::Tn5AraOut mutant was also more resistant to protamine and
rBALF, as compared to the parental strain, we wondered whether the feoC gene was
repressed in vivo, possibly increasing bacterial resistance to CAMPs, and thus improving
bacterial survival, growth and dissemination in an infected host. To test this possibility, the
parental strain KIM5 and an isogenic feoB mutant were administered together by the s.c.
route to C57BL/6 mice and dissemination of the two bacteria was studied over time.
Interestingly, the parental strain was always found in higher numbers than the feoB mutant
when bacteria were isolated from the livers and spleens (Fig. 6). Bacteria could not be
detected in the organs of many mice, indicating that Y. pestis KIM5 administered s.c. at the
dose used had been rapidly eliminated in the host. Although daily differences were
statistically significant in the liver only at day 4 (P < 0.005), differences of the aggregated
data for the four studied days were highly significant (P < 0.002 for the livers and P <
0.0004 for the spleens). These results suggested that feoB is expressed in vivo and improves
bacterial dissemination, possibly by increasing CAMP-resistance and/or purveying iron to
the multiplying bacteria.
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3. Discussion
Y. pestis encounters constitutively expressed CAMPs such as the cathelicidin LL-37 when it
accesses the lower respiratory tract or the skin after a fleabite [47]. We have previously
shown that cathelicidins and β-defensins have bactericidal activities towards Y. pestis and
that Pla inactivates these CAMPs [48]. Since the F1 protein inhibits the CAMP-inactivating
effect of Pla and both proteins are expressed in vivo, it is likely that Y. pestis utilizes other
mechanisms to resist CAMPs in host tissues. The goal of this study was to identify new Y.
pestis genes involved in CAMP resistance. Traditionally, such genes have been detected in
various pathogens by screening for CAMP sensitive mutants out of a library of knockout
mutants [49–51]. This approach implies that the “resistance” genes are expressed in vitro.
Here, we used a minitransposon engineered with an inducible promoter to identify genes
that need to be repressed or activated for detection of CAMP resistance. By selecting
mutants for increased resistance towards CAMPs, we focused on genes that could be
beneficial to bacterial survival in vivo whether repressed or activated, as determined with
null mutations or inducible promoter insertions, respectively.
The used protocol identified several genes encoding proteins that were previously described
in other bacteria to be involved directly or indirectly in the organization of the outer
membrane. For example, a mutation resulting in an inducible polymyxin B resistance was
related to the activation of the pbgP operon which decorates the phosphates of lipid A with
4-aminoarabinose, an LPS modification reported to increase polymyxin B resistance in
various bacteria [31]. Other genes involved in polymyxin B resistance detected in this study,
such as asmA [34–36] and hflC [37, 38] have been previously shown to have indirect effect
on LPS levels in the outer membrane. Consistent with a reduction in LPS levels, we
observed that polymyxin B binding to the surface of the corresponding mutants was
reduced. Whether import machineries for phosphate (PitA, GlpQ-like protein) and galactose
(MglBAC) have indirect effects on species structures and compositions of membrane lipids
that can explain CAMP resistance remains to be studied.
The y1522 and y3910 genes were investigated in more details since their gene products were
potentially involved in modulating new mechanisms of CAMP-resistance. Expression of the
Hcp-like protein encoded by the y1522 gene determined CAMP resistance, irrespective of
whether induced expression was from the ara promoter of the minitransposon or from the
trc promoter of a complementing plasmid in a y1522 mutant. Hcp proteins are type 6
secreted proteins that form hexameric rings suggested to assemble in a tubular system for
effector molecule delivery to eukaryotic cells [52, 53]. Similar to some hcp genes of other
bacteria, y1522 is an orphan hcp gene (i.e. unlinked to any of the T6SS gene clusters). Hcp
proteins are either secreted or tightly associated to bacterial surfaces [33, 52, 54].
Interestingly, the y1522 gene product was not secreted or detected in bacterial membranes
under the growth conditions used. Thus, it remains possible that the y1522 product is only
secreted under specific conditions that were not duplicated here. Alternatively, artificial
expression of the Hcp-like product of y1522 without activated expression of its
corresponding T6SS might not result in secretion. Finally, expression of the Hcp-like
product of y1522 might result in activation of an intracellular response that indirectly leads
to CAMP resistance independent of type 6 secretion. Although a Y. pestis mutant lacking
one of its Hcp molecule was not attenuated in models of bubonic or pneumonic plague,
replication of this mutant in J774.A1 macrophages was limited, suggesting some
nonessential role of a T6SS in Y. pestis pathogenesis [55].
CAMP resistance of the feoC::Tn5AraOut mutant was duplicated with a feoC (y3910)
deletion mutant, confirming that the phenotype was due to the disruption of feoC. FeoC has
been proposed to be a repressor of the feoAB operon [45], which encodes one of the two
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ferrous iron uptake systems of Y. pestis, the other one being encoded by the yfeABCD genes
[56]. Consistent with the regulatory role of FeoC, FeoC-independent expression of FeoA
and FeoB mimicked the CAMP-resistant phenotype obtained with the feoC mutant.
Moreover, a feoBC deletion mutant was as sensitive to CAMP as the parental non-mutated
strain. Taken together, these data indicated that induction of FeoAB expression increased
CAMP resistance and supported a regulatory role for FeoC. How activation of ferrous iron
uptake into the bacterial cytoplasm results by itself in CAMP resistance is not clear. One
potential mechanism is that this resistance was directed by the Y. pestis Fur protein, which
differentially regulates a large number of proteins, including membrane proteins [46]. This
would be consistent with our finding that feoC−-mediated resistance to all tested CAMPs
was linked to decreased polymyxin B-binding, suggesting some membrane modifications.
Moreover, intracellular iron acts as a co-regulator of the Fur protein to down-regulate iron
uptake systems, protecting the bacterial cell against the toxic effects of the Fenton reaction
[57]. In addition, Fur activates the expression of various scavenging proteins of oxidative
intermediates, including catalase [46, 58]. Consistent with the activation of the Fur pathway,
the feoC mutant was also more resistant to peroxide than the parental strain. A feoB mutant
of Y. pestis was attenuated in a competition assay with the parental strain after s.c.
administration to mice, highlighting the bacterial use of its Feo system in vivo to augment
virulence. Similarly, E. coli or Salmonella feoA or feoB mutants demonstrated reduced
virulence properties in mice models of infections [45]. Interestingly, Y. pestis has two
ferrous uptake systems (Yfe and Feo) and both systems were shown to be needed but
redundant for optimal Y. pestis growth in a murine macrophage cell line [56]. A yfe mutant
had a 100-fold increased LD50 after s.c. infection of mice [59]. In vivo studies with a feo yfe
double mutant might show a more drastic effect on virulence and bring further evidence to
the current data that supports a role for intra-macrophage survival of Y. pestis in the early
stages of plague [60]. Additional studies will be needed to differentiate the contributions of
the feo genes in iron replenishment and CAMP resistance for the intracellular survival and
growth of Y. pestis. Interestingly, another study has recently linked iron uptake with
polymyxin B resistance in Y. pseudotuberculosis, a coregulator of the yfe and pbgP genes
being responsible for both phenotypes [61].
Finally, this study illustrates a clear dissociation between the resistance profiles of Y. pestis
mutants towards polymyxin B, protamine and rBALF/LL-37. Increased resistance of the
hflC or pitA mutants was specific for polymyxin B or for protamine, respectively. Moreover,
only three of the protamine-resistant and none of the polymyxin B-resistant mutants showed
increased resistance towards rBALF, known to contain at least rCRAMP and rat β-defensin
1 [48]. The three rBALF-resistant mutants were also resistant to human cathelicidin LL-37,
whereas growth of the polymyxin B-resistant mutant PB7-23 with an activated pbgP operon
was significantly affected by LL-37. The latter result was surprising since LL-37 was
described to activate the PhoPQ two-component system in Salmonella [62], which itself
activates the pbgP operon in Salmonella and Y. pestis [31]. Whether mammalian CAMPs are
not good activators of the Y. pestis PhoPQ system, aminoarabinose decoration of LPS
doesn’t protect Y. pestis significantly from LL-37 or the experimental conditions used were
suboptimal to detect an effect remains to be determined. Previously detected differences
between polymyxin B, cecropin A and/or defensin A resistance of Y. pestis phoP or lpxM
lpxP or Y. pseudotuberculosis pbgP operon mutants remained essentially unexplained [13,
63, 64]. Nevertheless, accumulating evidence indicates that CAMP resistance is CAMP-type
specific and that this specificity is determined by a variety of bacterial genes, particularly
those capable of modulating directly or indirectly the bacterial surface architecture,
including the composition and content of its protein and lipid species.
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4. MaterIals and Methods
4.1. Bacterial strains, growth conditions and reagents
Bacterial strains and plasmids used in this study are listed in Table 1. Media and media
components were from Difco (BD Diagnostics, Sparks, MD). Y. pestis strains were grown
overnight in brain heart infusion (BHI) broth at 26°C, diluted to an A 600 of 0.1 in BHI and
further grown at 37°C. For colony selection, Y. pestis was grown on BHI or TB agar (10 g
tryptose, 2.5 g NaCl, 3.0 g Bacto beef extract paste and 1.5% Bacto-agar per liter) for 24–48
h at 26°C for colony counts or at 37°C for mutant selection. For quantitative RT-PCR,
bacteria grown at 26°C in heart Infusion (HI) were sub-cultured in HI for 4 h at 37°C. E. coli
strains were grown at 37°C in LB broth or agar. When required, the media were
supplemented with kanamycin (Km, 45 mg/l), ampicillin (Ap, 200 mg/l) or chloramphenicol
(Cm, 20 mg/l). When appropriate, the arabinose and lactose promoters were induced with
0.2% L-arabinose and 1mM IPTG, respectively, using X-Gal (40 mg/l) as chromogenic
substrate with the latter. Reagents, including polymyxin B sulfate salt and salmon protamine
sulfate salt were from Sigma-Aldrich Corp. (St Louis, MO), and LL-37 was from AnaSpec
(Fremont, CA). Rat bronchoalveolar lavage fluid (rBALF) was generously supplied by
Sandra R. Bates-Kenney, and was shown to contain the cathelicidin rCRAMP and rat β-
defensin 1 [48].
4.2. Construction and testing of plasmid pTn5AraOut
Preliminary studies showed that the minitransposon miniTn5 of pRL27 transposed
efficiently in KIM6. Plasmid pTn5AraOut was engineered by inserting the EcoRI fragment
of pNJ17 that contains the araC gene and PBAD promoter [65] into the SwaI site of pRL27,
which carries a miniTn5 delivery vector [66]. The araC-PBAD DNA fragment was blunted
by filling in its protruding ends with the Klenow fragment of DNA polymerase before the
ligation reaction. A successful construct carrying the miniTn5 with PBAD facing out was
identified by restriction analysis and renamed pTn5AraOut. Preliminary studies showed that
the minitransposon of pRL27 transposed efficiently in KIM6 and the transposition efficiency
of Tn5AraOut was only marginally lower than that of pRL27. To test the function of the
arabinose-dependent promoter in Tn5AraOut, E. coli DH5α harboring the promoter-trap
plasmid pRS415 was transformed with pTn5AraOut and the bacteria were screened for β-
galactosidase activity on LB agar plates containing Ap, Km, X-gal and L-arabinose. Bacteria
isolated from Lac+ (blue) colonies were shown by restriction analysis to harbor Tn5AraOut
upstream of the lacZ gene in pRS415. Arabinose-dependent induction was further confirmed
on MacConkey agar plates.
4.3. Minitransposon mutagenesis, mutant selection and screening
Y. pestis strain DSY101 was randomly mutagenized with the minitransposon Tn5AraOut.
For this, plasmid pTn5AraOut was introduced into strain DSY101 by 20 independent
electroporations, using in parallel water as negative controls. After 3 h recovery at 26°C, the
bacteria were incubated in ka namycin-containing BHI broth at 37°C, overnight, in a roller
drum. Mutants resistant to antimicrobial peptides were then selected on TB-kanamycin agar
plates containing 0.2% L-arabinose and supplemented with polymyxin B (4 mg/l, 4 × MIC)
or protamine (1 g/l, 1 × MIC on agar plates) after incubation at 37°C for 2–3 days. Colonies
were isolated and re sistance to the corresponding cationic antimicrobials was verified by
growing the bacteria to an A600 of 0.6 in BHI-kanamycin broth with 0.2% L-arabinose at
37°C and plating in duplicate 0.01 ml onto corresponding cationic antimicrobial selection
agar plates. Growth was inspected after incubation at 37°C for 1–3 days. Because of the
intrinsic property of Y. pestis to aggregate [67, 68], most consistent absorbance data (A600)
were obtained by growing the bacteria in glass tubes and dissociating the aggregated
bacteria by strong vortex mixing just before absorbance readings. Bacteria were grown at
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37°C to an A600 of 0.3 in 3 ml BHI-kanamycin broth, with 0.2% L-arabinose or 0.2% D-
glucose when appropriate to differentiate arabinose-dependent from arabinose-independent
resistance. Serial two-fold dilutions of polymyxin B (1.25–5 mg/l) were directly added to
such cultures. In contrast, dilutions of protamine (0.2 – 0.8 g/l), rat bronchoalveolar lavage
fluid (rBALF, 30 – 240 μg protein/ml), LL-37 (20 – 160 μg/ml) or H2O2 (1 – 32 mM) were
added to BHI cultures, prepared as described above and diluted 10-fold. The latter dilutions
were needed to use concentrations of inhibitors that did not interfere significantly with A600
readings. The experiments with rBALF were done with 0.5 ml cultures and the ones with
LL-37 were done with 0.1 ml cultures in smaller tubes. The bacterial cultures were further
incubated in a roller drum or agitated at 37°C for 18 hours, when final A600 values were
checked, or CFUs were determined for the LL-37 experiment.
4.4. Determination of MICs
Y. pestis DSY101 and its derived mutants being unable to grow significantly at 37°C in
small volumes of cation-adjusted Mueller-Hinton broth (100 μl/well, 96-well microtiter
plate; according to the NCCLS, now CLSI, guidelines), MICs were evaluated by the
following method. Briefly, bacteria were grown to an A600 of 0.08 – 0.1 in BHI broth at
37°C, diluted 10 fold in BHI (approximately 10 6 CFU/ml), and distributed into round-
bottom wells of 96-well microtiter plates (105 CFU/well). Serial two-fold dilutions of the
various antimicrobials were prepared in triplicates and MICs were determined after
overnight incubation on a rotary shaker at 37°C. MI Cs were defined as the lowest
concentration of antimicrobials that inhibited visible growth.
4.5. Southern blotting, subcloning and sequencing of minitransposon insertion sites
To check for single insertions by Southern blotting, genomic DNA was extracted from
parental strain Y101 or minitransposon mutants (DNA purification kit, Gentra, USA) and
digested with StyI or HpaI and separated on a 0.8% Seakem LE agarose gel. DNA was then
transferred to Nytran SPC nylon membranes (GE Healthcare BioSciences Corp.,
Piscataway, NJ) by the capillary transfer method. A 575-bp coding region of the kanamycin
resistance gene that lacks StyI and HpaI sites was amplified from pTn5AraOut with primers
PrMK150 and PrMK151 (Table 2), labeled with the DIG High Prime DNA Labeling and
Detection Starter Kit II (Roche, Indianapolis, IN) and used for hybridization as described by
the supplier. To clone minitransposon insertion sites, genomic DNA of each mutant was
digested with either one of a variety of restriction enzymes. Subsequently, the digested DNA
was treated with T4 DNA ligase and used to transform E. coli CC118λpir by electroporation.
Circularized DNA fragments containing the Tn5AraOut replicated as plasmids, most clones
originating from genomic DNA originally restricted with BclI or BamHI. The plasmids were
isolated and served as template for DNA sequencing, using a pair of outward-facing primers
(pTn5AraOutUP and pTn5AraOutLOW, Table 2) that anneal to the oriR6K or araC-PBAD
ends of the minitransposon. The Y. pestis KIM genome [69] was analyzed by BLAST [70]
with the obtained sequences to determine the minitransposon insertion sites.
4.6. Quantitative RT-PCR
HI broth cultures of bacteria grown to log-phase at 37°C were split in two and grown further
in the presence of 0.2% arabinose or glucose for 20 minutes. The cells were pelleted at 6000
× g for 10 min at 4°C and RNA was extracted using Trizol reagent (Invitrogen Corp.,
Carlsbad, CA) according to the manufacturer’s protocol. Residual genomic DNA
contamination in 10 μg RNA samples was removed by treating with the Turbo DNA-free
Kit (Ambion, Austin, TX). RNA concentration was determined with the ND1000
spectrophotometer (NanoDrop products, Wilmington, DE) and RNA integrity was verified
by agarose gel electrophoresis. Four hundred nanogram of RNA was used in reverse
transcription reactions using random hexamer primers and Superscript RTIII Reverse
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Transcriptase (Invitrogen Corp.) according to manufacturer’s protocol. Quantitative Real-
Time RT-PCR was carried out using cDNA corresponding to 20 ng RNA, gene-specific
primers (Table 2) and the Power SYBR Green PCR Master Mix with the ABI Fast 7500
Real-Time PCR System (Applied Biosystems, Foster City, CA). Expression levels were
normalized to the transcription levels for the house keeping gene rpoB [20]. Statistical
significance of compared results between the parental strain and mutants or arabinose-
induced and non-induced conditions was determined by the unpaired t-test (P < 0.05).
4.7. Preparation and analysis of LPS
LPS was prepared and resolved by SDS-PAGE as described elsewhere [71]. Briefly,
overnight bacterial cultures were diluted to an A600 of 0.5, and the cell pellets from 1 ml
aliquots were suspended in 50 μl of lysis buffer (2% SDS, 4% 2-mercaptoethanol, 10%
glycerol, 1 M Tris-HCl [pH 6.8], 0.002% bromophenol blue). The samples were heated at
100°C for 10 min, cooled to room temperature, and incubated with 25 μg of proteinase K
(Roche Diagnostics, Mannheim, Germany) at 60°C for 1 h. The sample preparations were
resolved by electrophoresis on a 12% polyacrylamide gel at 150 V, and the gels were silver
stained (Silver Stain Kit; Bio-Rad, Hercules, CA).
4.8. Dansyl-polymyxin B binding test
Bacteria were grown at 37°C to an A 600 of approximately 0.3 – 0.4 in 3 ml BHI broth.
Bacteria were twice centrifuged and resuspended in PBS, adjusted to an A600 of 0.3 and 3
ml aliquots were concentrated by centrifugation and resuspension in 400μl PBS. Half of this
bacterial suspension was supplemented with dansyl-polymyxin B (Molecular Probes,
Eugene, OR) to a final concentration of 2 μg/ml, whereas the other half was used as negative
control to evaluate background fluorescence. After incubation at 37°C for 5 minutes, the
bacteria were centrifuged and washed twice in PBS, resuspended in 400μl PBS and used for
fluorescence microscopy or fluorometry. For the latter analysis, the bacterial suspension was
transferred to transparent flat-bottom 96-well microtiter plates in triplicate. The A600 and
fluorescence values were read with a BioTek’s Synergy™ HT Microplate Reader. The
following calculations were done: Standardized fluorescence (arbitrary units or A.U.) value
= (fluorescence (A.U.)/A600)test − (fluorescence (A.U.)/A600)control. Data were presented as
means ± SD of three separate experiments and statistical significance was determined by the
unpaired t-test.
4.9. Construction of deletion mutants and plasmids, and complementation assays
Some of the genes targeted by Tn5AraOut were deleted from strain DSY101 by using the
lambda red recombination system [72]. Briefly, primers flanking the corresponding genes
were designed and used with pKD4 (Table 2) as template to prepare amplicons for the
replacement of the target genes with a kanamycin cassette. Strain DSY101 carrying the
lambda red plasmid pSIM9 (Table 1) was grown to log phase at 26°C, the red recombinase
genes were induced for 15 min at 42°C, and the bacteria were transformed by
electroporation with the gel-purified amplicons. Kanamycin-resistant recombinants were
selected on BHI agar and verified by colony PCR, using primers that hybridize to flanking
sequences of the target genes. Mutants cured of pSIM9 were selected by bacterial growth at
37°C. Using this ap proach, deletion mutants were engineered for genes y1522(hcp-like),
y1523, y3910(feoC) and y3910–3911(feoCB) in strain DSY101, and for gene y3911 in strain
KIM5. The resulting strains were designated DSY131, DSY132, DSY135, DSY136 and
DSY137, respectively (Table 1). Moreover, genes y1522, or y3911 and y3912(feoA)
together, were cloned by PCR into the NcoI-XmaI sites of the expression plasmid pTrc99A
for complementation studies. The generated plasmids were designated pHcpy1522 and
pFeoAB, respectively (Table 1). Gene y1522 was also cloned by PCR into the NdeI-XhoI
restriction sites of pET22b(+) to generate plasmid pETHcp (Table 1). Mutants
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complemented with plasmid constructs or with the empty vector were grown in BHI broth
overnight at 26°C, sub-cultured in BHI with IPTG (0.1 mM) at 37°C and grown for 2–3 h to
an A 600 of 0.3. Polymyxin B was added (1.25–5 mg/l) and further growth was monitored
(A600) after 18 hours at 37°C.
4.10. Expression and purification of the Hcp-like protein
The Hcp-like protein encoded by y1522 was expressed and purified from E. coli
BL21(DE3)pETHcp following the standard protocol (Qiagen, Valencia, CA). The protein
antigen was used to prepare polyclonal rabbit antisera (Cocalico Biologicals, Inc.). To
determine whether the protein was secreted, bacteria and spent media of a 10 ml culture
(BHI, 37°C for 18 h) were studied by SDS-PAGE and W estern blot. For this, spent media
were first filtered (Millex, MF-milliporeTM, 0.22 μm, Millipore, Billerica, MA),
concentrated to 1 ml (Amicon Ultra-15, 10 kDa, Millipore), precipitated in 10% TCA and
the pellet was rinsed twice in 0.5 ml cold acetone before being resuspended in 100 μl sample
buffer and split in two for SDS-PAGE and Western blot analysis. The gels were stained with
Coomassie Blue and the blots were probed with the specific antibody, HRP-conjugated
secondary antibody and enhanced chemiluminescence substrate [73].
4.11. Infection of mice
Six to eight week old female C57BL/6 mice were purchased from the Jackson Laboratories.
The mice were provided food and fresh water ad libitum during the experiments, which were
performed following the guidelines of the University of Pennsylvania Institutional Animal
Care and Use Committee. Bacteria were grown at 26°C, washed two times by centrifugation
and suspension steps in sterile PBS. Numbers of colony-forming units (CFU) inoculated
were determined by plating serial dilutions onto TB agar plates [48]. Mice were anesthetized
(ketamine/xylazin 100/10mg/kg body weight intra-peritoneally, i.p.) and infected
subcutaneously (s.c.) with 3×107 CFU each of KIM5 and DSY137 (KIM5 feoB) in 200μl
PBS. At days 1, 2, 4 and 5, livers and spleens were surgically removed and homogenized in
5 ml sterile PBS by using a Stomacher Lab Blender (Seward Medical Limited). CFU/organ
were determined by plating serial dilutions onto TB agar plates containing or lacking
kanamycin. CFUs for KIM5 were calculated by subtracting the DSY137 CFUs (Km plates)
from the total CFUs (no antibiotic). Competitive index (C.I.) scores were calculated as the
ratio of the KIM5 CFUs to the DSY137 CFUs. Statistical significance was determined by
the paired t-test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank Jun (Jay) Zhu and Mark Goulian for plasmids, Sandra Bates for the gifts of rat broncheoalveolar lavage
fluid. This work was supported by NIH grant RAI076695, a University of Pennsylvania Research Foundation grant
and Research Initiative Funds from the University of Pennsylvania Veterinary Center for Infectious Disease to
DMS. JG was a two-year visiting student from Beijing University, supported by the China Scholarship Council
(CSC).
References
1. Liu F, Chen H, Galván EM, Lasaro MA, Schifferli DM. Effects of Psa and F1 on the adhesive and
invasive interactions of Yersinia pestis with human respiratory tract epithelial cells. Infect Immun.
2006; 74:5636–44. [PubMed: 16988239]
Guo et al. Page 12
Microb Pathog. Author manuscript; available in PMC 2012 September 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
2. Huang XZ, Lindler LE. The pH 6 antigen is an antiphagocytic factor produced by Yersinia pestis
independent of Yersinia outer proteins and capsule antigen. Infection and immunity. 2004; 72:7212–
9. [PubMed: 15557646]
3. Du Y, Rosqvist R, Forsberg A. Role of fraction 1 antigen of Yersinia pestis in inhibition of
phagocytosis. Infection and immunity. 2002; 70:1453–60. [PubMed: 11854232]
4. Galván EM, Chen H, Schifferli DM. The Psa fimbriae of Yersinia pestis interact with
phosphatidylcholine on alveolar epithelial cells and pulmonary surfactant. Infect Immun. 2007;
2007:1272–9.
5. Cornelis GR. The Yersinia Ysc-Yop ‘type III’ weaponry. Nat Rev Mol Cell Biol. 2002; 3:742–52.
[PubMed: 12360191]
6. Viboud GI, Bliska JB. Yersinia Outer Proteins: Role in Modulation of Host Cell Signalling
Responses and Pathogenesis. Annu Rev Microbiol. 2005; 59:69–89. [PubMed: 15847602]
7. Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, Goldsmith EJ, et al. Yersinia YopJ acetylates and
inhibits kinase activation by blocking phosphorylation. Science. 2006; 312:1211–4. [PubMed:
16728640]
8. Lemaitre N, Sebbane F, Long D, Hinnebusch BJ. Yersinia pestis YopJ suppresses tumor necrosis
factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not
required for virulence in a rat model of bubonic plague. Infection and immunity. 2006; 74:5126–31.
[PubMed: 16926404]
9. Brubaker RR. Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV
(V antigen). Infection and immunity. 2003; 71:3673–81. [PubMed: 12819047]
10. Depaolo RW, Tang F, Kim I, Han M, Levin N, Ciletti N, et al. Toll-like receptor 6 drives
differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague
pathogenesis. Cell Host Microbe. 2008; 4:350–61. [PubMed: 18854239]
11. Ye Z, Kerschen EJ, Cohen DA, Kaplan AM, van Rooijen N, Straley SC. Gr1+ Cells Control
Growth of YopM-Negative Yersinia pestis during Systemic Plague. Infection and immunity. 2009
12. Montminy SW, Khan N, McGrath S, Walkowicz MJ, Sharp F, Conlon JE, et al. Virulence factors
of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nature immunology.
2006; 7:1066–73. [PubMed: 16980981]
13. Rebeil R, Ernst RK, Gowen BB, Miller SI, Hinnebusch BJ. Variation in lipid A structure in the
pathogenic Yersiniae. Molecular microbiology. 2004; 52:1363–73. [PubMed: 15165239]
14. Robinson RT, Khader SA, Locksley RM, Lien E, Smiley ST, Cooper AM. Yersinia pestis evades
TLR4-dependent induction of IL-12(p40)2 by dendritic cells and subsequent cell migration. J
Immunol. 2008; 181:5560–7. [PubMed: 18832714]
15. Velan B, Bar-Haim E, Zauberman A, Mamroud E, Shafferman A, Cohen S. Discordance in the
effects of Yersinia pestis on the dendritic cell functions manifested by induction of maturation and
paralysis of migration. Infection and immunity. 2006; 74:6365–76. [PubMed: 16923789]
16. Zhang P, Skurnik M, Zhang SS, Schwartz O, Kalyanasundaram R, Bulgheresi S, et al. Human DC-
SIGN (CD209) is a receptor for Yersinia pestis that promotes phagocytosis by dendritic cells.
Infection and immunity. 2008
17. Zhang SS, Park CG, Zhang P, Bartra SS, Plano GV, Klena JD, et al. Plasminogen activator Pla of
Yersinia pestis utilizes murine DEC-205 (CD205) as a receptor to promote dissemination. The
Journal of biological chemistry. 2008; 283:31511–21. [PubMed: 18650418]
18. Cathelyn JS, Crosby SD, Lathem WW, Goldman WE, Miller VL. RovA, a global regulator of
Yersinia pestis, specifically required for bubonic plague. Proceedings of the National Academy of
Sciences of the United States of America. 2006; 103:13514–9. [PubMed: 16938880]
19. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A surface protease and
the invasive character of plague. Science. 1992; 258:1004–7. [PubMed: 1439793]
20. Felek S, Tsang TM, Krukonis ES. Three Yersinia pestis adhesins facilitate Yop delivery to
eukaryotic cells and contribute to plague virulence. Infection and immunity. 2010; 78:4134–50.
[PubMed: 20679446]
21. Sodeinde OA, Sample AK, Brubaker RR, Goguen JD. Plasminogen activator/coagulase gene of
Yersinia pestis is responsible for degradation of plasmid-encoded outer membrane proteins. Infect
Immun. 1988; 56:2749–52. [PubMed: 2843471]
Guo et al. Page 13
Microb Pathog. Author manuscript; available in PMC 2012 September 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
22. Lahteenmaki K, Virkola R, Saren A, Emody L, Korhonen TK. Expression of plasminogen
activator pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular
matrix. Infect Immun. 1998; 66:5755–62. [PubMed: 9826351]
23. Welkos SL, Friedlander AM, Davis KJ. Studies on the role of plasminogen activator in systemic
infection by virulent Yersinia pestis strain C092. Microb Pathog. 1997; 23:211–23. [PubMed:
9344782]
24. Sebbane F, Jarrett CO, Gardner D, Long D, Hinnebusch BJ. Role of the Yersinia pestis
plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne
plague. Proceedings of the National Academy of Sciences of the United States of America. 2006;
103:5526–30. [PubMed: 16567636]
25. Lathem WW, Price PA, Miller VL, Goldman WE. A plasminogen-activating protease specifically
controls the development of primary pneumonic plague. Science. 2007; 315:509–13. [PubMed:
17255510]
26. Kerschen EJ, Cohen DA, Kaplan AM, Straley SC. The plague virulence protein YopM targets the
innate immune response by causing a global depletion of NK cells. Infection and immunity. 2004;
72:4589–602. [PubMed: 15271919]
27. Endsley JJ, Torres AG, Gonzales CM, Kosykh VG, Motin VL, Peterson JW, et al. Comparative
Antimicrobial Activity of Granulysin against Bacterial Biothreat Agents. Open Microbiol J. 2009;
3:92–6. [PubMed: 19587798]
28. Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial
resistance. Nat Rev Microbiol. 2006; 4:529–36. [PubMed: 16778838]
29. Nizet V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues
Mol Biol. 2006; 8:11–26. [PubMed: 16450883]
30. Higuchi K, Carlin CE. Studies on the nutrition and physiology of Pasteurella pestis. I. A casein
hydrolyzate medium for the growth of Pasteurella pestis. Journal of bacteriology. 1957; 73:122–9.
[PubMed: 13405873]
31. Winfield MD, Latifi T, Groisman EA. Transcriptional regulation of the 4-amino-4-deoxy-L-
arabinose biosynthetic genes in Yersinia pestis. The Journal of biological chemistry. 2005;
280:14765–72. [PubMed: 15710615]
32. Yan A, Guan Z, Raetz CR. An undecaprenyl phosphate-aminoarabinose flippase required for
polymyxin resistance in Escherichia coli. The Journal of biological chemistry. 2007; 282:36077–
89. [PubMed: 17928292]
33. Bingle LE, Bailey CM, Pallen MJ. Type VI secretion: a beginner’s guide. Curr Opin Microbiol.
2008; 11:3–8. [PubMed: 18289922]
34. Misra R, Miao Y. Molecular analysis of asmA, a locus identified as the suppressor of OmpF
assembly mutants of Escherichia coli K-12. Molecular microbiology. 1995; 16:779–88. [PubMed:
7476172]
35. Xiong X, Deeter JN, Misra R. Assembly-defective OmpC mutants of Escherichia coli K-12.
Journal of bacteriology. 1996; 178:1213–5. [PubMed: 8576061]
36. Deng M, Misra R. Examination of AsmA and its effect on the assembly of Escherichia coli outer
membrane proteins. Molecular microbiology. 1996; 21:605–12. [PubMed: 8866482]
37. Gottesman S. Proteolysis in bacterial regulatory circuits. Annu Rev Cell Dev Biol. 2003; 19:565–
87. [PubMed: 14570582]
38. Inagawa T, Kato J, Niki H, Karata K, Ogura T. Defective plasmid partition in ftsH mutants of
Escherichia coli. Mol Genet Genomics. 2001; 265:755–62. [PubMed: 11523792]
39. Langklotz S, Schakermann M, Narberhaus F. Control of lipopolysaccharide biosynthesis by FtsH-
mediated proteolysis of LpxC is conserved in enterobacteria but not in all gram-negative bacteria.
Journal of bacteriology. 2011; 193:1090–7. [PubMed: 21193611]
40. Jackson RJ, Binet MR, Lee LJ, Ma R, Graham AI, McLeod CW, et al. Expression of the PitA
phosphate/metal transporter of Escherichia coli is responsive to zinc and inorganic phosphate
levels. FEMS Microbiol Lett. 2008; 289:219–24. [PubMed: 19054109]
41. Willsky GR, Malamy MH. Characterization of two genetically separable inorganic phosphate
transport systems in Escherichia coli. Journal of bacteriology. 1980; 144:356–65. [PubMed:
6998957]
Guo et al. Page 14
Microb Pathog. Author manuscript; available in PMC 2012 September 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
42. Richarme G, Caldas TD. Chaperone properties of the bacterial periplasmic substrate-binding
proteins. The Journal of biological chemistry. 1997; 272:15607–12. [PubMed: 9188448]
43. Semsey S, Krishna S, Sneppen K, Adhya S. Signal integration in the galactose network of
Escherichia coli. Molecular microbiology. 2007; 65:465–76. [PubMed: 17630975]
44. Tommassen J, Eiglmeier K, Cole ST, Overduin P, Larson TJ, Boos W. Characterization of two
genes, glpQ and ugpQ, encoding glycerophosphoryl diester phosphodiesterases of Escherichia
coli. Mol Gen Genet. 1991; 226:321–7. [PubMed: 1851953]
45. Cartron ML, Maddocks S, Gillingham P, Craven CJ, Andrews SC. Feo--transport of ferrous iron
into bacteria. Biometals. 2006; 19:143–57. [PubMed: 16718600]
46. Zhou D, Qin L, Han Y, Qiu J, Chen Z, Li B, et al. Global analysis of iron assimilation and fur
regulation in Yersinia pestis. FEMS Microbiol Lett. 2006; 258:9–17. [PubMed: 16630248]
47. Dürr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelicidin
family of antimicrobial peptides. Biochim Biophys Acta. 2006; 1758:1408–25. [PubMed:
16716248]
48. Galván EM, Lasaro MA, Schifferli DM. Capsular antigen fraction 1 and Pla modulate the
susceptibility of Yersinia pestis to pulmonary antimicrobial peptides such as cathelicidin. Infection
and immunity. 2008; 76:1456–64. [PubMed: 18227173]
49. Groisman EA, Parra-Lopez C, Salcedo M, Lipps CJ, Heffron F. Resistance to host antimicrobial
peptides is necessary for Salmonella virulence. Proc Natl Acad Sci U S A. 1992; 89:11939–43.
[PubMed: 1465423]
50. Parra-Lopez C, Baer MT, Groisman EA. Molecular genetic analysis of a locus required for
resistance to antimicrobial peptides in Salmonella typhimurium. Embo J. 1993; 12:4053–62.
[PubMed: 8223423]
51. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Gotz F. Inactivation of the dlt operon in
Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial
peptides. The Journal of biological chemistry. 1999; 274:8405–10. [PubMed: 10085071]
52. Pukatzki S, McAuley SB, Miyata ST. The type VI secretion system: translocation of effectors and
effector-domains. Curr Opin Microbiol. 2009; 12:11–7. [PubMed: 19162533]
53. Leiman PG, Basler M, Ramagopal UA, Bonanno JB, Sauder JM, Pukatzki S, et al. Type VI
secretion apparatus and phage tail-associated protein complexes share a common evolutionary
origin. Proceedings of the National Academy of Sciences of the United States of America. 2009
54. Pieper R, Huang ST, Robinson JM, Clark DJ, Alami H, Parmar PP, et al. Temperature and growth
phase influence the outer-membrane proteome and the expression of a type VI secretion system in
Yersinia pestis. Microbiology (Reading, England). 2009; 155:498–512.
55. Robinson JB, Telepnev MV, Zudina IV, Bouyer D, Montenieri JA, Bearden SW, et al. Evaluation
of a Yersinia pestis mutant impaired in a thermoregulated type VI-like secretion system in flea,
macrophage and murine models. Microbial pathogenesis. 2009; 47:243–51. [PubMed: 19716410]
56. Perry RD, Mier I Jr, Fetherston JD. Roles of the Yfe and Feo transporters of Yersinia pestis in iron
uptake and intracellular growth. Biometals. 2007; 20:699–703. [PubMed: 17206386]
57. Imlay JA. Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem. 2008;
77:755–76. [PubMed: 18173371]
58. Pieper R, Huang ST, Parmar PP, Clark DJ, Alami H, Fleischmann RD, et al. Proteomic analysis of
iron acquisition, metabolic and regulatory responses of Yersinia pestis to iron starvation. BMC
Microbiol. 2010; 10:30. [PubMed: 20113483]
59. Bearden SW, Perry RD. The Yfe system of Yersinia pestis transports iron and manganese and is
required for full virulence of plague. Molecular microbiology. 1999; 32:403–14. [PubMed:
10231495]
60. Bliska JB, Casadevall A. Intracellular pathogenic bacteria and fungi--a case of convergent
evolution? Nat Rev Microbiol. 2009; 7:165–71. [PubMed: 19098923]
61. Arafah S, Rosso ML, Rehaume L, Hancock RE, Simonet M, Marceau M. An iron-regulated LysR-
type element mediates antimicrobial peptide resistance and virulence in Yersinia
pseudotuberculosis. Microbiology (Reading, England). 2009; 155:2168–81.
62. Bader MW, Sanowar S, Daley ME, Schneider AR, Cho U, Xu W, et al. Recognition of
antimicrobial peptides by a bacterial sensor kinase. Cell. 2005; 122:461–72. [PubMed: 16096064]
Guo et al. Page 15
Microb Pathog. Author manuscript; available in PMC 2012 September 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
63. Rebeil R, Ernst RK, Jarrett CO, Adams KN, Miller SI, Hinnebusch BJ. Characterization of late
acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation.
Journal of bacteriology. 2006; 188:1381–8. [PubMed: 16452420]
64. Marceau M, Sebbane F, Ewann F, Collyn F, Lindner B, Campos MA, et al. The pmrF polymyxin-
resistance operon of Yersinia pseudotuberculosis is upregulated by the PhoP-PhoQ two-
component system but not by PmrA-PmrB, and is not required for virulence. Microbiology
(Reading, England). 2004; 150:3947–57.
65. Judson N, Mekalanos JJ. TnAraOut, a transposon-based approach to identify and characterize
essential bacterial genes. Nature biotechnology. 2000; 18:740–5.
66. Larsen RA, Wilson MM, Guss AM, Metcalf WW. Genetic analysis of pigment biosynthesis in
Xanthobacter autotrophicus Py2 using a new, highly efficient transposon mutagenesis system that
is functional in a wide variety of bacteria. Arch Microbiol. 2002; 178:193–201. [PubMed:
12189420]
67. Felek S, Lawrenz MB, Krukonis ES. The Yersinia pestis autotransporter YapC mediates host cell
binding, autoaggregation and biofilm formation. Microbiology (Reading, England). 2008;
154:1802–12.
68. Kolodziejek AM, Sinclair DJ, Seo KS, Schnider DR, Deobald CF, Rohde HN, et al. Phenotypic
characterization of OmpX, an Ail homologue of Yersinia pestis KIM. Microbiology (Reading,
England). 2007; 153:2941–51.
69. Deng W, Burland V, Plunkett G 3rd, Boutin A, Mayhew GF, Liss P, et al. Genome sequence of
Yersinia pestis KIM. J Bacteriol. 2002; 184:4601–11. [PubMed: 12142430]
70. Cummings L, Riley L, Black L, Souvorov A, Resenchuk S, Dondoshansky I, et al. Genomic
BLAST: custom-defined virtual databases for complete and unfinished genomes. FEMS Microbiol
Lett. 2002; 216:133–8. [PubMed: 12435493]
71. Hitchcock PJ, Brown TM. Morphological heterogeneity among Salmonella lipopolysaccharide
chemotypes in silver-stained polyacrylamide gels. Journal of bacteriology. 1983; 154:269–77.
[PubMed: 6187729]
72. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12
using PCR products. Proc Natl Acad Sci U S A. 2000; 97:6640–5. [PubMed: 10829079]
73. Chen H, Schifferli DM. Mucosal and systemic immune responses to chimeric fimbriae expressed
by Salmonella enterica Serovar Typhimurium vaccine strains. Infect Immun. 2000; 68:3129–39.
[PubMed: 10816454]
74. Herrero M, De Lorenzo V, Timmis KN. Transposon vectors containing non-antibiotic resistance
selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative
bacteria. J Bacteriol. 1990; 172:6557–67. [PubMed: 2172216]
75. Goguen JD, Yother J, Straley SC. Genetic analysis of the low calcium response in Yersinia pestis
mu d1(Ap lac) insertion mutants. Journal of bacteriology. 1984; 160:842–8. [PubMed: 6094509]
76. Simons RW, Houman F, Kleckner N. Improved single and multicopy lac-based cloning vectors for
protein and operon fusions. Gene. 1987; 53:85–96. [PubMed: 3596251]
77. Datta S, Costantino N, Court DL. A set of recombineering plasmids for gram-negative bacteria.
Gene. 2006; 379:109–15. [PubMed: 16750601]
78. Amann E, Ochs B, Abel KJ. Tightly regulated tac promoter vectors useful for the expression of
unfused and fused proteins in Escherichia coli. Gene. 1988; 69:301–15. [PubMed: 3069586]
Guo et al. Page 16
Microb Pathog. Author manuscript; available in PMC 2012 September 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig 1.
Bacterial growth with the CAMPs used to select the mutants. (A) Bacteria were grown in
BHI with or without glucose or arabinose to an A600 of 0.3 at 37°C, polymyxin B was added
to a concentration of 5 μg/ml (or a0.625 μg/ml, b1.25 μg/ml, and c2.5 μg/ml), the cultures
were further incubated for 18 h before measuring growth (A600). MICs were determined in
microtiter plates and were 1 μg/ml for DSY101 and 8 μg/ml for all the mutants (except
PB7-10, 4 μg/ml). (B) Bacteria were grown in BHI to an A600 of 0.3 at 37°C, diluted to an
A 600 of 0.05 (to use concentrations of protamine that do not interfere significantly with
A600 reading), protamine was added to a concentration of 0.4 mg/ml and the cultures were
further incubated for 18 h before measuring growth (A600). MICs were determined in
microtiter plates and were 0.4 mg/ml for DSY101 and 0.8 mg/ml for all the mutants. All the
data are means of at least three independent experiments with standard errors.
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Fig 2.
Bacterial growth with CAMPs different from the ones used to select the mutants. (A) The
polymyxin B-resistant mutants and the parental strain DSY101 were grown in BHI to an
A600 of 0.3 at 37°C, diluted to an A 600 of 0.05, protamine was added to a concentration of
0.4 mg/ml and the cultures were further incubated for 18 h before measuring growth (A600).
MICs were determined in microtiter plates and were 0.8 mg/ml for all the mutants. (B) The
protamine-resistant mutants were grown in BHI to an A600 of 0.3 at 37°C, polymyxin B was
added to a concentrati on of a1.25 μg/ml or b5 μg/ml, the cultures were further incubated for
18 h before measuring growth (A600). MICs were determined in microtiter plates and were 1
μg/ml (PM2-3, PM3-2 ) or 16 μg/ml (PM2-49, PM5-6 and PM12-3). All the data are means
of at least three independent experiments with standard errors.
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Fig 3.
Bacterial growth of all the mutants in the presence of rBALF or LL-37. (A) Bacteria were
grown in BHI to an A600 of 0.3 at 37°C, diluted to an A 600 of 0.08, rBALF was added to a
concentration of 60 μg/ml protein and the cultures were further incubated for 18 h before
measuring growth (A600). MICs were determined in microtiter plates and were 60μg/ml
protein for DSY101, all the polymyxin B mutants, PM2-3 and PM3-2, and 120 μg/ml
protein for PM2-49, PM5-6 and PM12-3. (B) Bacteria were grown in BHI to an A600 of 0.3
at 37°C, diluted to an A 600 of 0.08, LL-37 was added to 20, 40, 80 or 160 μg/ml protein and
the cultures were further incubated for 18 h before determining bacterial survival (CFUs).
All the data are means of at least three independent experiments with standard errors.
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Fig 4.
Binding of polymyxin B to bacterial surfaces. Standardized concentrations of bacteria were
incubated with dansyl-polymyxin B for fluorometric analysis and determination of arbitrary
units (A.U.) of fluorescence, as described in Material and Methods. All the data are means
of at least three independent experiments with standard errors. Unpaired t-tests comparing
each mutant to the parental strain DSY101 showed statistical significant differences for
several comparisons (* P < 0.05, ** P < 0.001).
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Fig 5.
Growth of feo mutants and complemented strains in the presence of polymyxin B. (A)
Bacteria were grown in BHI to an A600 of 0.3 at 37°C, polymyxin B was added to a
concentration of a1.25 μg/ml or b5 μg/ml, the cultures were further incubated for 18 h before
measuring growth (A600). All the data are means of at least three independent experiments
with standard errors.
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Fig 6.
Y. pestis KIM5 and DSY137 (KIM5 feoB) competition experiment in mice. C57BL/6 mice
were challenged s.c. with a 1:1 mixture of KIM5 and DSY137 (3×107 CFU each). Five mice
were sacrificed on days 1, 2, 4 and 5 and CFUs were determined in livers (A) and spleens
(B) to calculate competitive index (C.I.) scores (KIM5 CFUs divided by the DSY137
CFUs). C.I. scores for each mouse are shown as diamonds and bars represent geometric
means.
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Table 1
Bacterial strains and plasmids
Strain or plasmid Description Source
E. coli
 CC118λpir Δ(ara-leu) ΔaraD lacX74 galE galK phoA thi-1 rpsE rpoB argE(Am) recA1, lysogenized
with λpir phage
[74]
 DH5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1
hsdR17
Invitrogen Corp.,
Carlsbad, CA
 BL21(DE3) E. coli B (DE3)[F− dcm ompT hsdSB (rB− mB−)] Novagen, EMD Biosc.,
Madison, WI
Y. pestis
 KIM5 Y. pestis KIM pgm [75]
 KIM6 KIM5 pCD1− (LCR−) [75]
 DSY88 KIM6 Δcaf Δpsa pPCP1ΩaphA Δpla [48]
 DSY101 DSY88 PCP1Δpla This study
 DSY131 DSY101 Δy1522::aphA This study
 DSY132 DSY101 Δy1523::aphA This study
 DSY133 DSY131 pTrc99A This study
 DSY134 DSY131 pHcpy1522 This study
 DSY135 DSY101 Δy3910(feoC)::aphA This study
 DSY136 DSY101 Δy3910–y3911(feoBC)::aphA This study
 DSY137 KIM5 Δy3911(feoB)::aphA This study
Plasmids
 pNJ17 TnAraOut delivery vehicle; Kmr [65]
 pRL27 Plasmid with mini-Tn5 and oriR6K; Kmr [66]
 pTn5AraOut pRL27 with araC-PBAD from pNJ17; Kmr This study
 pRS415 lacZ transcriptional fusion vector; Apr [76]
 pSIM9 pRK2 gam exo bet; Cmr [77]
 pKD4 Plasmid with the Kmr template for PCR [72]
 pET22b(+) Expression vector; His6 affinity tag; Apr Novagen
 pETHcp pET22b(+)-y1522; Apr This study
 pTrc99A Expression vector with trc (trp-lac) promoter; Apr [78]
 pHcpy1522 pTrc99A-y1522 This study
 pFeoAB pTrc99A-y3911–y3912 This study
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Table 2
Primers
Name Sequence 5′ – 3′
Tn5AraOutUP tgccatagcatttttatccat
Tn5AraOutLOW aacaagccagggatgtaacg
dinP-PrMK140 ggtaagtttggtcgcgtattgtgg
dinP-PrMK141 atcctcggccagtgttttctcc
pmrH-PrMK142 cgagatcaatggattggtgagcag
pmrH-PrMK143 gaacttaagccgacggactctgg
mglB-PrMK144 gtattgctggctaagggcgtgaaag
mglB-PrMK145 gtagctatccaatgccttgcgagaag
16SrDNA-PrMK146 gtgtgaagaaggccttcgggttg
16SrDNA-PrMK147 ttagccggtgcttcttctgcgag
rpoB-PrMK148 tgctgtacaacgcacgtatcatccc
rpoB-PrMK149 caggcaatttacggcgacggtc
PrMK150 tcgggcaatcaggtgcgacaatctat
PrMK151 gtctgcgattccgactcgtccaacat
y1522KOUP aataataagggatggtgtaggccatccccgaataaagtgtaggctggagctgcttc
y1522KOLOW ccctgcatcttgaaggcgacgggtatataaggacatcatatgaatatcctccttag
y1522VFUP tcaccccctgaggatatagat
y1522VFLOW ggatgagcaagggcaactaac
y1523KOUP gaagctgtcctcagtatgaccacgtaggaaaccaggtgcggtgtaggctggagctgcttc
y1523KOLOW tcgccataaccagagcggagcctcagttcttggaacccgtcatatgaatatcctccttag
y1523VFUP caggcgagcggttattctatc
y1523VFLOW ctccatgtcggcttaactgtt
feoCKOUP attgatcacccattagccagccgtaaaaagagggggaacggtgtaggctggagctgcttc
feoCKOLOW atacggaatcaacatattgagatgcccatatgggcatctccatatgaatatcctccttag
feoCVFUP tcacccattagccagccgtaa
feoCVFLOW gctgacgccgaggtttat
feoBKOUP cgcgcagtttgattttaatttattgatatcacgttggatcgtgtaggctggagctgcttc
feoBKOLOW cgttgagggcaatcgcatcacgtagttgcagtaggctggccatatgaatatcctccttag
feoBVFUP ttctatctgcgctacggtttg
feoBVFLOW gctgatggccttcgggaca
y1522CMUP gactcccgggttaatacacgcgatcatcccat
y1522CMLOW gactcgtctcccatgagaatggctaacatgatt
feoABCMUP gactcgtctcccatgcatcttatcccccaacgatcctacaaa
feoABCMLOW gactcccgggtttttacggctggctaatgggtga
pETHCP-UP gactcatatgagaatggctaacatgatt
pETHCP-LOW gactctcgagatacacgcgatcatcccagatgctataaccact
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